plasmid and lentiviral reagents, and end-to-end contract screening projects. Vivlion’s screening services cover experimental design, cell engineering, pooled CRISPR screens, and next-generation sequencing-based readouts such as viability assays, flow cytometry and reporter-based phenotyping, and single-cell RNA sequencing. The company also supplies bioinformatics support through tools like ReCo Data Analytics for read counting, hit calling, and genetic interaction analysis. These products and services are used by pharmaceutical and biotechnology R&D groups, screening facilities, and academic researchers to identify drug targets, study genetic interactions, and investigate disease mechanisms.